TABLE 5.
PET‐CT comparison during all treatment periods (preand post‐therapy).
| Site | October 26, 2015 | July 1, 2016 | February 17, 2017 | August 19, 2017 | April 12, 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Size | SUV | Size | SUV | Size | SUV | Size | SUV | Size | SUV | |
| Left axillary‐node | 27 × 14 mm | 11.97 | Resolved | — | — | — | — | |||
| Pre tracheal‐nodes | 25 × 28 mm | 4.78 | Reduced | 2.62 | Resolved | — | — | — | ||
| Lateral segment of Right Middle‐lobe | 16 × 19 mm | 2.84 | reduced | Resolved | — | — | — | |||
| Left paraaortic node | 21 × 21 mm | 11.11 | Reduced in size and metabolic activity | 7.18 | Resolved | — | — | — | ||
| Lesion in B/l ureter | 97 × 75 × 173 mm | 12.75 | Reduced | 9.18 | Resolved | — | — | — | ||
| Left adrenal nodule | 13 × 11 mm | 2.3 | Persistent | 3.83 | Increased | 4.13 | Persistent | 4.13 | Persistent | |
| New Right inguinal node | — | — | 24 × 32 mm | 22.31 | Increased | 12.33 | Persistent | Reduced | ||
| 39 × 35 mm | 9.77 | |||||||||
| Right externa liliac node mass | — | — | 11 mm | 12.54 | Decreased 6 mm | 3.08 | Reduced | 3.7 | ||
| Left proximal common iliac mass | — | — | 42 × 44 mm | 23.08 | Decreased | 10.62 | Decrease | 10.62 | ||
| 41 × 43 mm | 39 × 44 mm | |||||||||
| New deposit in right iliacus | — | — | 16 mm | 13.6 | Persistent | — | Increased | Decreased | ||
| 16 × 24 mm | 7.98 | |||||||||
| Lung nodule in right upper lobe | — | — | — | 8.62 | 5.32 | Increased | Decreased | |||
| 20 mm | 6.63 | |||||||||
| Lung nodule in right lower lobe | 10 | 4.52 | Increased 27 × 23 mm | 5.74 | ||||||
| New deposit posterior to left rectus abdominis | — | — | — | 17 mm | 4.31 | |||||
| Conclusion | Partial tumor response (PR) | Progression of disease (PD) | Partial tumor response (PR) | Mixed response overall disease progression | ||||||